# SPG Block for Acute Pediatric Migraine

> **NCT03984045** · PHASE3 · UNKNOWN · sponsor: **Newark Beth Israel Medical Center** · enrollment: 72 (estimated)

## Conditions studied

- Migraine in Children
- Sphenopalatine Neuralgia
- Migraine in Adolescence

## Interventions

- **DRUG:** Lidocaine topical
- **DRUG:** Prochlorperazine Injection

## Key facts

- **NCT ID:** NCT03984045
- **Lead sponsor:** Newark Beth Israel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-06
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984045, "SPG Block for Acute Pediatric Migraine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03984045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*